Catalent Has Added Early Development & Spray Dry Capabilities With Pharmatek Laboratories
The acquisition provides leading drug development and delivery technologies to help Catalent's pharmaceutical partners unlock the full potential of their molecules and provide better treatments for patients
Catalent has Acquired Pharmatek Laboratories, Adding Extensive Early Phase Development and Spray Dry Capabilities to Provide A Fully Comprehensive Portfolio of Drug Development And Bioavailability Enhancement Solutions
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired West Coast based drug development and clinical manufacturing specialist, Pharmatek. The acquisition is adding extensive early-phase drug development capabilities from discovery to clinic, bring spray drying into Catalent’s portfolio of drug development and delivery technologies, expand Catalent’s high potent handling capability with specialized facilities and controls, and enhance Catalent’s OptiForm® Solution Suite for bioavailability enhancement.
- Combined company now offers the most comprehensive suite of early drug development and delivery technologies and services from discovery to market
- A full range of services for the development and clinical manufacturing of Spray Dry Dispersions, as well as specialized facilities and controls for handling highly potent compounds
- The most comprehensive platform for bioavailability enhancement, expanding OptiForm® Solution Suite with established spray dry expertise
- Together, we offer the broadest technology portfolio to solve complex development challenges, with integrated manufacturing and supply services to help customers unlock the full potential of their molecule and provide better treatments to patients
This acquisition strengthens Catalent’s position as the #1 partner in drug development and delivery. By offering the broadest, most comprehensive expertise in selection and implementation of drug formulation technologies and optimized dose design, Catalent can help their customers reduce risk and accelerate their key drug development programs from discovery to market.
Contact Us about how we can help solve your development challenges.